Regulatory ApprovalLucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil 05.06.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

An executive order from the Trump administration has reintroduced the “most favored nation” (MFN) policy, which aims to cut ...

The image-guided therapy systems market is projected to grow at a CAGR of ~5% over the forecast period. Major factors driving ...

The HLA typing market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the growth ...

The point-of-care ultrasound devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors ...

The pharmaceutical excipients market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the increasing demand ...

The urology ultrasound devices market is projected to grow at a CAGR of 6%, driven by the rising prevalence of urological ...

JRM Construction Management is excited to announce the successful completion of a comprehensive renovation project of the ...

The global single-cell analysis Market is expected to witness a growth rate of 14% in the next five years. Continuous ...

The fetal monitoring bands market is experiencing steady growth, with a projected CAGR of approximately 7% over the forecast ...

The Artificial Intelligence in Healthcare Marke was valued at USD 22.23 billion in 2024 and is expected to reach USD 629.09 ...